期刊文献+

观察苦参碱联合化疗治疗进展期胃癌的疗效 被引量:4

Matrine combined chemotherapy treatment of advanced gastric cancer
下载PDF
导出
摘要 目的:观察苦参碱联合化疗治疗进展期胃癌的疗效。方法:收治进展期胃癌患者80例,随机分成观察组和对照组,每组40例,其中对照组给予单纯的化疗,而观察组给予苦参碱联合化疗。观察期为2周,并对所得结果进行整合评价。结果:治疗组的有效率55%,对照组的有效率47.5%。差异无统计学意义(P>0.05)。在生活质量方面,治疗组提高率40%,对照组提高率25%,差异具有统计学意义(P<0.05)。两组发生不良反应的概率差异有统计学意义。结论:用苦参碱联合化疗的方法治疗进展期胃癌不仅能提高患者的生活质量,还能减轻化疗的不良反应。对于进展期胃癌的患者有卓越的疗效。 Objective:To observe the therapeutic effect of matrine combined with chemotherapy for advanced gastric cancer. Methods:Patients with advanced gastric cancer were treated 80 patients were randomly divided into observation group and control group 40 cases,in which the control group received chemotherapy alone,while the observation group were given matrine chemotherapy.Observation period of two weeks,and to integrate the results of the evaluation.Results:The response rate of 55% in the control group and 47.5% efficiency.The difference was not significant(P>0.05),with statistical significance.In terms of quality of life,the treatment group improved 40%,increase the rate of 25% in the control group, the difference was statistically significant(P<0.05).The probability of the occurrence of side effects between the two groups was significant.Conclusion:The method matrine chemotherapy treatment of advanced gastric cancer can not only improve the quality of life of patients,but also reduce the toxicity of chemotherapy.For patients with advanced gastric cancer have superior efficacy,and therefore deserve promotion in clinical practice.
作者 张中良
出处 《中国社区医师(医学专业)》 2014年第6期86-87,共2页
关键词 苦参碱 进展期胃癌 化疗 Matrine Advanced gastric cancer Chemotherapy
  • 相关文献

参考文献3

二级参考文献20

  • 1戴支凯,余丽梅,杨小生,石京山,文国容.刺梨提取物CL对胃癌细胞的抑制作用[J].贵州医药,2005,29(9):786-789. 被引量:23
  • 2许国平,张春妮,汪俊军,周毓,刘琦,李克,张双全.刺梨汁和诺丽汁对人卵巢癌细胞株COC_2抑制作用的研究[J].临床检验杂志,2006,24(2):137-139. 被引量:16
  • 3戴支凯,余丽梅,杨小生.刺梨提取物(CL)抗肿瘤作用[J].中国中药杂志,2007,32(14):1453-1457. 被引量:22
  • 4Ferrara N,Kerbgel RS. Angiogenesis as a therapeutic target [J]. Nature, 2005,438 (70) : 967-- 974. 被引量:1
  • 5Chou TC. Theoretical basis, experimental design,and computerized simulation of synergism and antagonism in drug combination studies [J].Pharmacol Rev,2007,59(1):621--681. 被引量:1
  • 6Uchide K, Sakon M, Ariyoshi H, et al. Cancer cells cause vascular endothelial cell (VEGC) retraction via 12 (S)HETE secretion;the possible role of cancer cell derived microparticle [J]. Ann Surg Onco,2007,14 (2):862--868. 被引量:1
  • 7Reihill JA, Ewart MA, Hardie DG, et al. AMP- activated protein kinase mediates VEGF-stimulated endothelial NO production [J]. Biochem Biophys Res Commun, 2007,354 (4) : 1084-- 1088. 被引量:1
  • 8Presta M, DelI'Era P, Mitola S, et al. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis [J]. Cytokine Growth Factor Rev, 2005,16 (2) : 159-- 178. 被引量:1
  • 9Folkman J, Haudenschild CC, Zetter BR, et al. Long- term culture of capillary endothelial ceils [J].Proc Natl Acad Sci USA, 1979,76(10) : 5217--5218. 被引量:1
  • 10Lu N, Gao Y, Ling Y, Chen Y, et al. Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2 [J]. Life Sci,2008,23;82(17-18): 956--963. 被引量:1

共引文献3

同被引文献69

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部